Jenscare Scientific Co., Ltd.

SEHK:9877 Stock Report

Market Cap: HK$1.3b

Jenscare Scientific Future Growth

Future criteria checks 2/6

Jenscare Scientific is forecast to grow earnings and revenue by 96.3% and 137.2% per annum respectively while EPS is expected to grow by 96.7% per annum.

Key information

96.3%

Earnings growth rate

96.7%

EPS growth rate

Medical Equipment earnings growth39.9%
Revenue growth rate137.2%
Future return on equityn/a
Analyst coverage

Low

Last updated05 Aug 2024

Recent future growth updates

No updates

Recent updates

Here's Why We're Not At All Concerned With Jenscare Scientific's (HKG:9877) Cash Burn Situation

May 15
Here's Why We're Not At All Concerned With Jenscare Scientific's (HKG:9877) Cash Burn Situation

Companies Like Jenscare Scientific (HKG:9877) Are In A Position To Invest In Growth

Jan 11
Companies Like Jenscare Scientific (HKG:9877) Are In A Position To Invest In Growth

Earnings and Revenue Growth Forecasts

SEHK:9877 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025484-17N/A2641
12/31/2024206-317N/A111
6/30/2024N/A-298-296-239N/A
3/31/2024N/A-335-298-231N/A
12/31/2023N/A-372-301-222N/A
9/30/2023N/A-457-273-207N/A
6/30/2023N/A-542-246-191N/A
3/31/2023N/A-491-214-175N/A
12/31/2022N/A-439-182-158N/A
9/30/2022N/A-322-175-153N/A
6/30/2022N/A-205-168-148N/A
3/31/2022N/A-353-163-145N/A
12/31/2021N/A-501-157-142N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 9877 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 9877 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 9877 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 9877's revenue (137.2% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 9877's revenue (137.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 9877's Return on Equity is forecast to be high in 3 years time


Discover growth companies